A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma
Conditions: Lymphoma; DLBCL; T Cell Lymphoma Intervention: Drug: Selinexor Sponsor: Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials